#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Comparison of the inoculum size effects of antibiotics on IMP-6 β-lactamase-producing Enterobacteriaceae co-harboring plasmid-mediated quinolone resistance genes


Autoři: Yoshihiko Ogawa aff001;  Ryuichi Nakano aff002;  Kei Kasahara aff001;  Tomoki Mizuno aff002;  Nobuyasu Hirai aff001;  Akiyo Nakano aff002;  Yuki Suzuki aff002;  Naoki Kakuta aff002;  Takashi Masui aff002;  Hisakazu Yano aff002;  Keiichi Mikasa aff001
Působiště autorů: Center for Infectious Diseases, Nara Medical University, Kashihara, Japan aff001;  Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan aff002
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0225210

Souhrn

Almost all cases of carbapenemase-producing Enterobacteriaceae infections in Japan are caused by blaIMP-positive Enterobacteriaceae (especially blaIMP-6) and infections caused by other types of carbapenemase-producing Enterobacteriaceae are quite rare. We examined drug resistance genes co-harboring with blaIMP-6 and their inoculum size effects. We screened β-lactamase genes, plasmid-mediated quinolone resistance (PMQR) genes, and aminoglycoside-modifying enzyme genes by PCR and performed sequencing for 14 blaIMP-6-positive Enterobacteriaceae. Further, all PMQR-positive isolates were submitted to conjugation and inoculum effect evaluation. Our data showed that 13 of the 14 isolates harbored CTX-M-2 and one co-harbored CTX-M-2 and CTX-M-1 as extended-spectrum β-lactamases. All isolates carried one or more PMQRs; aac(6’)-Ib-cr was the most prevalent (92.8%), and was followed by oqxA (64.3%), qnrS (50%), oqxAB (21.4%), and qnrB (14.3%). However, Klebsiella pneumoniae contains chromosomal OqxAB. Inoculum size effects were significant in all strains for meropenem, 13 strains for imipenem, 7 for levofloxacin, and 3 for amikacin. We observed that 11 of the experimental strains (100%), 8 strains (72.7%), and 1 strain showed inoculum size effects for meropenem, imipenem, and amikacin, respectively. However, four strains harbored qnr genes and two strains harbored qnr genes and QRDR mutations concurrently; no inoculum size effect was seen for levofloxacin. The blaIMP-6-positive Enterobacteriaceae that we studied was found to harbor at least one plasmid-mediated drug resistance gene. The inoculum size effect for carbapenems was thought to be mainly due to IMP-6-type metallo-β-lactamase; however qnrB and qnrS also had a minimal impact on the inoculum size effect for levofloxacin.

Klíčová slova:

Antibiotic resistance – Antibiotics – Antimicrobial resistance – Drug screening – Enterobacteriaceae – Polymerase chain reaction – Enterobacter infections


Zdroje

1. van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013;75 : 115–120. doi: 10.1016/j.diagmicrobio.2012.11.009 23290507

2. Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014;58 : 2322–2328. doi: 10.1128/AAC.02166-13 24514083

3. Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. 2015. Open Forum Infect Dis 2:ofv050. doi: 10.1093/ofid/ofv050 26125030

4. Yano H, Ogawa M, Endo S, Kakuta R, Kanamori H, Inomata S, et al. High frequency of IMP-6 among clinical isolates of metallo-beta-lactamase-producing Escherichia coli in Japan. Antimicrob Agents Chemother 2012;56 : 4554–4555. doi: 10.1128/AAC.00617-12 22664972

5. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001;45 : 1343–1348. doi: 10.1128/AAC.45.5.1343-1348.2001 11302793

6. Kanazawa S, Sato T, Kohira N, Ito-Horiyama T, Tsuji M, Yamano Y. Susceptibility of imipenem-susceptible but meropenem-resistant BlaIMP-6 carrying Enterobacteriaceae to various antibacterials, including the siderophore cephalosporin cefiderocol. Antimicrob Agents Chemother 2017;66: e00576–e00517.

7. Pang F, Jia XQ, Zhao QG, Zhang Y. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob 2018;17 : 13. doi: 10.1186/s12941-018-0267-8 29571291

8. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006;6 : 629–640. doi: 10.1016/S1473-3099(06)70599-0 17008172

9. Margaritis A, Galani I, Chatzikonstantinou M, Petrikkos G, Souli M. Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat. J Med Microbiol 2017;66 : 266–275. doi: 10.1099/jmm.0.000397 27902429

10. Yanat B Rodríguez-Martínez JM, Touati A. Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. Eur J Clin Microbiol Infect Dis 2017;36 : 421–435. doi: 10.1007/s10096-016-2847-x 27889879

11. Wu N, Chen BY, Tian SF, Chu YZ. The inoculum effect of antibiotics against CTX-M-extended-spectrum beta-lactamase-producing Escherichia coli. Ann Clin Microbiol Antimicrob 2014;13 : 45. doi: 10.1186/s12941-014-0045-1 25213463

12. Adler A, Ben-Dalak M, Chmelnitsky I, Carmeli Y. Effect of resistance mechanisms on the inoculum effect of carbapenem in Klebsiella pneumoniae isolates with borderline carbapenem resistance. Antimicrob Agents Chemother 2015;59 : 5014–5017. doi: 10.1128/AAC.00533-15 25987630

13. Garoff L, Yadav K, Hughes D. Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli. J Antimicrob Chemother 2018 : 73 : 348–352. doi: 10.1093/jac/dkx375 29106520

14. Nakano A, Nakano R, Suzuki Y, Saito K, Kasahara K, Endo S, et al. Rapid identification of bla(IMP-1) and bla(IMP-6) by multiplex amplification refractory mutation system PCR. Ann Lab Med 2018;38 : 378–380. doi: 10.3343/alm.2018.38.4.378 29611391

15. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect 2011;70 : 119–123.

16. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, et al. PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006;50 : 791–795. doi: 10.1128/AAC.50.2.791-795.2006 16436748

17. Guillard T, Moret H, Brasme L, Carlier A, Vernet-Garnier V, Cambau E, et al. Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. Diagn Microbiol Infect Dis 2011;70 : 253–259. doi: 10.1016/j.diagmicrobio.2011.01.004 21596225

18. Casin I, Hanau-Bercot B, Podglajen I, Vahaboglu H, Collatz E. Salmonella enterica serovar Typhimurium blaPER-1-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6'-N-acetyltransferase of Type Ib. Antimicrob Agents Chemother 2003;47 : 697–703. doi: 10.1128/AAC.47.2.697-703.2003 12543680

19. Park CH, Robicsek A. Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006;50 : 3953–3955. doi: 10.1128/AAC.00915-06 16954321

20. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother 2009;53 : 3582–3584. doi: 10.1128/AAC.01574-08 19528276

21. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 1999;43 : 727–737. 10103173

22. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Update 2010;13 : 151–171.

23. Galani I, Souli M, Mitchell N, Chryssouli Z, Giamarellou H. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece. Int J Antimicrob Agents 2010;36 : 252–254. doi: 10.1016/j.ijantimicag.2010.05.004 20580536

24. Nakano R, Okamoto R, Nakano A, Nagano N, Abe M, Tansho-Nagakawa S, et al. Rapid assay for detecting gyrA and parC mutations associated with fluoroquinolone resistance in Enterobacteriaceae. J Microbiol Methods 2013;94 : 213–216. doi: 10.1016/j.mimet.2013.06.019 23816531

25. Qiang YZ, Qin T, Fu W, Cheng WP, Li YS, Yi G. Use of a rapid mismatch PCR method to detect qyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother 2002;49 : 549–552. doi: 10.1093/jac/49.3.549 11864958

26. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard -⁠ Tenth Edition. Document M07-A10; Wayne, PU.

27. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; Twenty-Fifth informational supplement. Document M100-S250; Wayne, PU.

28. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters version 8.1. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_8.1_Breakpoint_Tables.pdf.

29. Rice LB. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clinic Proc. 2012;87 : 198–208.

30. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2013;56 : 2108–2113.

31. Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis 2009;64 : 233–235. doi: 10.1016/j.diagmicrobio.2009.02.004 19345034


Článek vyšel v časopise

PLOS One


2019 Číslo 11
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

BONE ACADEMY 2025
nový kurz
Autoři: prof. MUDr. Pavel Horák, CSc., doc. MUDr. Ludmila Brunerová, Ph.D, doc. MUDr. Václav Vyskočil, Ph.D., prim. MUDr. Richard Pikner, Ph.D., MUDr. Olga Růžičková, MUDr. Jan Rosa, prof. MUDr. Vladimír Palička, CSc., Dr.h.c.

Cesta pacienta nejen s SMA do nervosvalového centra
Autoři: MUDr. Jana Junkerová, MUDr. Lenka Juříková

Svět praktické medicíny 2/2025 (znalostní test z časopisu)

Eozinofilní zánět a remodelace
Autoři: MUDr. Lucie Heribanová

Hypertrofická kardiomyopatie: Moderní přístupy v diagnostice a léčbě
Autoři: doc. MUDr. David Zemánek, Ph.D., MUDr. Anna Chaloupka, Ph.D.

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#